Charles River Laboratories | CRL - Stock

Stock Price
186.73
Daily Change
3.03 1.65%
Monthly
-13.86%
Yearly
14.01%
Q1 Forecast
204.00

Charles River Laboratories reported $302.55M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Agilent USD 1.03B 11M Sep/2025
Align Technology USD 228.16M 15.59M Sep/2025
Bio-Rad Laboratories USD 783.2M 15.6M Sep/2025
Bruker USD 1.2B 21.7M Sep/2025
Cardinal Health USD 20.12B 2.56B Dec/2025
Charles River Laboratories USD 302.55M 23M Sep/2025
Cigna USD 5.63B 335M Sep/2025
CVS Health USD 18.96B 1.52B Sep/2025
Danaher USD 2.49B 185M Dec/2025
Dentsply International USD 686M 11M Sep/2025
Elevance Health USD 0 0 Dec/2024
Galapagos EUR 22.95M 15.57M Sep/2025
Hologic USD 688.5M 9.1M Dec/2025
Illumina USD 564M 26M Dec/2025
Incyte USD 83.45M 24K Sep/2025
Laboratory Of America USD 521.5M 13.4M Sep/2025
Lonza CHF 1.68B 163M Dec/2025
McKesson USD 27.07B 933M Dec/2025
Merck EUR 4.47B 45M Jun/2025
Mettler Toledo International USD 401.81M 13.73M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Quest Diagnostics USD 186M 1000K Sep/2025
Revvity USD 379.92M 8.55M Sep/2025
Thermo Fisher Scientific USD 5.43B 320M Dec/2025
United Therapeutics USD 176.5M 7.3M Sep/2025
UnitedHealth USD 280M 280M Dec/2023
Waters USD 572.94M 32.19M Sep/2025
West Pharmaceutical Services USD 438M 16.9M Sep/2025